Mucociliary dysfunction is a common sign of chronic obstructive pulmonary disease. Mucociliary clearance is a well-known innate defense system against microbes and irritants inhaled through the nose. The Saccharine Test in the sino-nasal system can be used to assess mucociliary clearance. The therapy for mucociliary clearance generally includes proteolytic enzymes to reduce mucus viscosity, vibrations for improving ciliary beat frequency, irrigation with Locke-Ringer's solution for cilia frequency, glucosteroids and surfactants.
This report contains market size and forecasts of Mucociliary Clearance and Dysfunction Treatment in Global, including the following market information:
Global Mucociliary Clearance and Dysfunction Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Mucociliary Clearance and Dysfunction Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mucociliary Clearance and Dysfunction Treatment include Vortran Medical Technology, Smiths Group, Monaghan, Hill-Rom Services, Allergan, Novartis, AstraZeneca, Merck and Regeneron Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mucociliary Clearance and Dysfunction Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mucociliary Clearance and Dysfunction Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Mucociliary Clearance and Dysfunction Treatment Market Segment Percentages, by Type, 2021 (%)
Medications
Surgery
Mucus Clearance Device
Others
Global Mucociliary Clearance and Dysfunction Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Mucociliary Clearance and Dysfunction Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Others
Global Mucociliary Clearance and Dysfunction Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Mucociliary Clearance and Dysfunction Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mucociliary Clearance and Dysfunction Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Mucociliary Clearance and Dysfunction Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Vortran Medical Technology
Smiths Group
Monaghan
Hill-Rom Services
Allergan
Novartis
AstraZeneca
Merck
Regeneron Pharmaceuticals
Abbott
F. Hoffmann-La Roche
Cadila Pharmaceuticals
Eisai
Cipla
Glenmark Pharmaceuticals Limited
Vertical Pharmaceuticals
TORAY INDUSTRIES
Pfizer